TY  - GEN
AU  - Merad,M
AU  - Angevin,E
AU  - Wolfers,J
AU  - Flament,C
AU  - Lorenzi,I
AU  - Triebel,F
AU  - Escudier,B
AU  - Zitvogel,L
TI  - Generation of monocyte-derived dendritic cells from patients with renal cell cancer: modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12)
SN  - 1524-9557
PY  - 2000///0816
KW  - Antibodies, Monoclonal
KW  - immunology
KW  - Carcinoma, Renal Cell
KW  - Cytokines
KW  - Dendritic Cells
KW  - drug effects
KW  - Drug Therapy, Combination
KW  - Granulocyte-Macrophage Colony-Stimulating Factor
KW  - Histocompatibility Antigens Class II
KW  - Humans
KW  - Immunologic Factors
KW  - administration & dosage
KW  - Interferon-alpha
KW  - Interleukin-12
KW  - Interleukin-2
KW  - Interleukin-4
KW  - Kidney Neoplasms
KW  - Lymphocyte Culture Test, Mixed
KW  - Melanoma
KW  - Monocytes
KW  - Neoplasm Metastasis
KW  - Peptides
KW  - Recombinant Proteins
KW  - therapeutic use
KW  - T-Lymphocytes
KW  - Tetanus Toxoid
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/00002371-200005000-00010
ER  -